Communication

Filter by

Keyword search

IN THE NEWS

  • NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

    Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset As provider of the bulk and single-cell RNA-seq libraries and sequencing, IntegraGen is proud of... Read More

  • BRIEF TECHNIQUE: LOW-PASS WHOLE GENOME SEQUENCING - GETTING MORE FROM LESS

    LP-WGS analysis of liquid biopsies (ctDNA) for oncology applications Background Analysis of circulating tumor DNA (ctDNA) offers great opportunities for cancer research and patient care. There are multiple... Read More

  • ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT "OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS" OF ONCODNA S.A.

    This press release has been prepared and issued by OncoDNA S.A. in accordance with the provisions of Articles 231-27 1° and 2° and 231-28 of the French General... Read More

LATEST NEWS

  • ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT "OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS" OF ONCODNA S.A.

    This press release has been prepared and issued by OncoDNA S.A. pursuant to... Read More

  • ASSEMBLÉE GÉNÉRALE MIXTE

    COMBINED GENERAL MEETING

    IntegraGen's Combined Ordinary and Extraordinary General Meeting will be held on September 17 at 2 pm... Read More

  • WHAT'S NEW FOR MERCURY?

    Latest update: MERCURY™ v3.0 We are delighted to present the new version... Read More

  • ACCORD EN VUE D’UNE OFFRE PUBLIQUE D’ACHAT AMICALE INITIÉE PAR ONCODNA SUR INTEGRAGEN

    AGREEMENT ON A FRIENDLY TAKEOVER BID BY ONCODNA FOR INTEGRAGEN

    Agreement to a friendly takeover bid initiated by ONCODNA for INTEGRAGEN at a price... Read More

en_US
en_US fr_FR